Inhibition of cervical cancer by promoting IGFBP7 expression using ellagic acid from pomegranate peel

Medical Science Monitor

Volumn 22, Issue , 2016, Pages 4881-4886

  Guo, Hongjun ^a   Zhang, Dongya ^a   Fu, Qingrui ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Ellagic acid; HeLa cells; Nephroblastoma overexpressed protein; Oncogene protein v akt

Indexed keywords

ELLAGIC ACID; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; POLYPHENOL; POMEGRANATE EXTRACT; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 7; UNCLASSIFIED DRUG; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS ASSAY; ARTICLE; CANCER CELL CULTURE; CELL INVASION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; MTT ASSAY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; WESTERN BLOTTING; APOPTOSIS; BIOSYNTHESIS; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; FEMALE; LYTHRACEAE; METABOLISM; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

APOPTOSIS; CELL PROLIFERATION; ELLAGIC ACID; FEMALE; HELA CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; PLANT EXTRACTS; PUNICACEAE; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 85006795653     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.898658     Document Type: Article

References (18)

1. Damas J, Remade VG: Ther thrombopenic effect of ellagic acid in the rat, another model of platelet stimulation in vivo. Thromn Res, 1987; 45: 153–63
2. Takuo K, Ishida H, Yokota M et al: Studies on antihemorrhagic substances in herbs classified as hemostatics in chinese medicine III on the antihemorrhagic principle in Sanguisorba officinallis L. Chem Pharm Bull (Tokyo), 1984; 32(11): 4478–81
3. Wu L, Jin L, Zhang W et al: Roles of long non-coding RNA CCAT2 in cervical cancer cell growth and apoptosis. Med Sci Monit, 2016; 22: 875–79
4. Lin F, Pan L, Li L et al: Effects of a simulated CO2 pneumoperitoneum environment on the proliferation, apoptosis, and metastasis of cervical cancer cells in vitro. Med Sci Monit, 2014; 20: 2497–503
5. Sudan S, Rupasinghe HF: Flavonoid-enriched apple fraction AF4 induces cell cycle arrest, DNA topoisomerase II inhibition, and apoptosis in human liver cancer HepG2 cells. Nutr Cancer, 2014; 66(7): 1237–46
6. Lall RK, Syed DN, Adhami VM et al: Dietary polyphenols in prevention and treatment of prostate cancer. Int J Mol Sci, 2015; 16(2): 3350–76
7. Bazhenov AG, Guseĭnov KD, Khadzhimba AV et al: Results of treatment for recurrent cancer of the uterine cervix. Vopr Onkol, 2009; 55(3): 319–26
8. Yan H, Liu Z, Fu X et al: Long-term outcomes of radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy after neoadjuvant chemotherapy for the IB1 cervical cancer: A series of 60 cases. Int J Surg, 2016; 29: 38–42
9. Bach A, Bender-Sigel J, Schrenk D et al: The antioxidant quercetin inhibits cellular proliferation via HIF-1-dependent induction of p21WAF. Antioxid Redox Signal, 2009; 9(2): 138–61
10. Wang Y, Zhang W, Lv Q et al: The critical role of quercetin in autophagy and apoptosis in HeLa cells. Tumour Biol, 2016; 37(1): 925–29
11. Fetoni AR, Paciello F, Mezzogon D et al: Molecular targets for anti-cancer redox chemotherapy and cisplatin-induced ototoxicity: The role of curcumin on pSTAT3 and Nrf-2 signalling. Br J Cancer, 2015; 113(10): 1434–44
12. Rigacci S, Micell C, Nediani C et al: Oleuropein aglycone induces autophagy via the AMPK/mTOR signalling pathway: A mechanistic insight. Oncotarget, 2015; 6(34): 35344–57
13. Zhu Q, Liang X, Dai J et al: Prostaglandin transporter, SLCO2A1, mediates the invasion and apoptosis of lung cancer cells via PI3K/AKT/mTOR pathway. Int J Clin Exp Pathol, 2015; 8(8): 9175–81
14. Riquelme I, Tapia O, Sandoyal A et al: miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Cell Oncol (Dordr), 2016; 39(1): 23–33
15. Yang L, Hou Y, Yuan J et al: Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways. Oncotarget, 2015; 6(28): 25755–69
16. Suzuki H, Igarashi S, Nojima M et al: IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methlator phenotype. Carcinogenesis, 2010; 31(3): 342–49
17. Vizioli MG, Sensi M, Miranda C et al: IGFB7: An onco-suppressor gene in thyroid carcinogenesis. Oncogene, 2010; 29(26): 3835–44
18. Kim EY, Kim A, Kim SK et al: Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3b signaling-mediated up-regulation of E-cadherin repressor complexes in non-small cell lung cancer cells. Respir Res, 2014; 15; 26